During the initial stages of the tumor, resident immune cells within the tissue microenvironment secrete the pro-inflammatory cytokine IL-1β, serving as a primary activator of NF-κB to initiate crosstalk between CAFs and tumor cells [131]. The gene discussed is IL1B; the disease is neoplasm.